DV
Dividend Vision

OCGN — Ocugen, Inc.

Ocugen, Inc. (OCGN)

Total return is -99.8% over the past 11.7 years, 454.4 points behind SPY at 354.6%. Its deepest 1-year drawdown was 52.4%.

This is a single-stock holding in Ocugen, Inc., a biopharmaceutical company, rather than a diversified ETF. The holding does not currently pay dividends, resulting in no distribution rate or yield profile. With no expense ratio data available and limited fund characteristics typical of ETFs, this appears to be equity exposure to a small-cap biotech company suited primarily for growth-oriented investors rather than income-focused investors seeking regular dividend distributions.

OCGN key facts

Asset type
Stock
Asset class
Equity
Inception date
12/03/2014
Last close
$1.35
Market cap
$457,799,040
Average volume
2969300.0
Payment date
09/30/2019
Beta
2.203
Payout ratio
0.0
Forward P/E
13.0719
EPS
$-0.26